13.2 Perioperative Nutrition & Enhanced Recovery After Surgery (ERAS)

13.2 Perioperative Nutrition & Enhanced Recovery After Surgery (ERAS)

Clinical Core: Enhanced Recovery After Surgery (ERAS) represents a multimodal, evidence-based paradigm that replaces empirical surgical dogma with scientifically validated perioperative care pathways. The primary metabolic objective of ERAS is to attenuate surgical stress, blunt postoperative insulin resistance, preserve lean muscle mass, and expedite gastrointestinal recovery. Key nutritional interventions include liberalizing preoperative fasting (clear liquids up to 2 hours pre-induction), administering preoperative complex carbohydrate loading ($45\text{--}50\text{ g}$ maltodextrin 2 hours prior to anesthesia), postponing major elective surgery for $7\text{ to } 14\text{ days}$ of specialized nutritional optimization in severe malnutrition, initiating early postoperative enteral feeding within 24 hours, and eliminating routine nasogastric tube decompression.

---

The Modern Perioperative Paradigm & ERAS Principles

Traditional surgical management subjected patients to prolonged periods of starvation, unphysiologic fluid overload, aggressive mechanical bowel cleansing, and extended post-procedure nasogastric decompression. These practices intensified the neuroendocrine stress response, accelerated skeletal muscle proteolysis, and induced profound catabolism.

+-----------------------------------------------------------------------------------------+
|                        TRADITIONAL SURGERY vs. MODERN ERAS PARADIGM                     |
+-----------------------------------------------------------------------------------------+
| Component             | Traditional Practice            | ERAS Protocol                 |
| --------------------- | ------------------------------- | ----------------------------- |
| Preoperative Fasting  | Strict NPO after midnight       | Clear liquids up to 2 hr pre-op|
|                       | (10 to 16 hours starvation)     | Light meal up to 6 hr pre-op  |
| --------------------- | ------------------------------- | ----------------------------- |
| Carbohydrate Status   | Starved, glycogen depleted      | Oral carbohydrate loading     |
|                       | Catabolic at incision           | (Maltodextrin 2 hr pre-op)    |
| --------------------- | ------------------------------- | ----------------------------- |
| Preoperative Nutrition| Surgery rushed regardless of    | Delay elective surgery 7-14 d |
| in Severe Malnutrition| severe nutritional depletion    | for nutrition optimization    |
| --------------------- | ------------------------------- | ----------------------------- |
| Nasogastric Tube      | Routine decompression until     | Avoided; selective use only   |
|                       | flatus / bowel movement         | for persistent emesis/ileus   |
| --------------------- | ------------------------------- | ----------------------------- |
| Postoperative Feeding | NPO until bowel sounds/flatus;  | Early oral diet or EN within  |
|                       | delayed 3 to 5+ days            | 24 hours of surgery           |
+-----------------------------------------------------------------------------------------+

The Neuroendocrine Surgical Stress Response

Surgical tissue trauma triggers afferent neural signals and systemic cytokine release ($\text{IL}-6$, $\text{TNF}-\alpha$, $\text{IL}-1$), stimulating the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system. Counter-regulatory hormones (cortisol, glucagon, epinephrine) surge, inducing:

1. Peripheral Insulin Resistance: Downregulation of glucose transporter-4 (GLUT-4) translocation in skeletal muscle, impairing glucose uptake;
2. Hepatic Gluconeogenesis & Glycogenolysis: Massive endogenous glucose production from amino acids (alanine, glutamine) and glycerol, resulting in stress hyperglycemia;
3. Muscle Proteolysis: Accelerated myofibrillar protein breakdown via the ubiquitin-proteasome pathway, generating negative nitrogen balance (losses of $-10\text{ to } -20\text{ g/day}$ of nitrogen, representing $300\text{ to } 600\text{ g/day}$ of wet muscle tissue loss);
4. Endothelial Dysfunction: Microvascular leakage, sodium and water retention, and impaired tissue oxygenation.

ERAS pathways systematically attenuate each component of this neuroendocrine stress response through standardized nutritional, anesthetic, and surgical interventions.

---

Preoperative Fasting Guidelines

For more than a century, surgical candidates were made strictly "NPO after midnight" based on empirical fears of pulmonary aspiration during anesthesia induction (Mendelson's syndrome). Modern physiological investigations utilizing gastric scintigraphy and magnetic resonance imaging have demonstrated that clear liquids empty from the stomach exponentially, with a gastric half-life of only $12\text{ to } 15\text{ minutes}$, completely clearing the stomach within $60\text{ to } 90\text{ minutes}$.

+-----------------------------------------------------------------------------------------+
|                        EVIDENCE-BASED PREOPERATIVE FASTING WINDOWS                      |
+-----------------------------------------------------------------------------------------+
| Ingested Substrate    | Description & Examples          | Minimum Fasting Interval      |
| --------------------- | ------------------------------- | ----------------------------- |
| Clear Liquids         | Water, clear fruit juice without| 2 Hours Prior to Induction    |
|                       | pulp, black coffee/tea, clear   | of Anesthesia                 |
|                       | carbohydrate maltodextrin drink |                               |
| --------------------- | ------------------------------- | ----------------------------- |
| Light Meal            | Toast, crackers, clear broth,   | 6 Hours Prior to Surgery      |
|                       | non-fatty liquids               |                               |
| --------------------- | ------------------------------- | ----------------------------- |
| Heavy / Fatty Meal    | Fried foods, fatty meats,       | 8 Hours Prior to Surgery      |
|                       | high-fat dairy products         |                               |
+-----------------------------------------------------------------------------------------+

• Harm of Prolonged Fasting: Fasting for $12\text{ to } 16\text{ hours}$ induces dehydration, hypovolemia, headache, severe thirst, and anxiety. Metabolically, it depletes hepatic glycogen stores and primes the patient in a catabolic, insulin-resistant state prior to surgical incision.
• Exclusions & Caution: The 2-hour clear liquid rule applies to patients without altered gastrointestinal motility. Patients with documented severe gastroparesis, known gastric outlet obstruction, achalasia, severe active gastroesophageal reflux disease, or those undergoing emergency surgery require individualized airway precautions and adjusted fasting intervals.

---

Preoperative Carbohydrate Loading

Preoperative carbohydrate loading is a cornerstone of the ERAS metabolic protocol, designed to convert the patient's metabolic state from a catabolic/fasted state to an anabolic/fed state prior to the induction of anesthesia.

1. Administration Protocol

• Evening Before Surgery: Oral ingestion of approximately $100\text{ g}$ of complex carbohydrates ($800\text{ mL}$ of a $12.5\%$ iso-osmolar maltodextrin beverage);
• Morning of Surgery: Oral ingestion of $45\text{ to } 50\text{ g}$ of complex carbohydrates ($400\text{ mL}$ of a $12.5\%$ maltodextrin beverage) completed $2\text{ hours}$ prior to the scheduled induction of anesthesia.

2. Physicochemical Properties: The Role of Maltodextrin

Maltodextrin is a complex carbohydrate polymer consisting of hydrolyzed starch oligosaccharides. Unlike simple mono- or disaccharide solutions (such as glucose or sucrose) which are hyperosmolar ($> 600\text{ mOsm/kg}$) and delay gastric emptying by stimulating duodenal osmoreceptors, maltodextrin has a high caloric density ($50\text{ g}$ in $400\text{ mL}$) with an exceptionally low osmolality ($130\text{ to } 140\text{ mOsm/kg}$). Consequently, it empties from the stomach rapidly and predictably, completely exiting the gastric lumen within 90 minutes.

3. Metabolic & Clinical Benefits

$$\text{Postoperative Insulin Resistance Reduction} \approx 50\%$$ $$\text{Hospital Length of Stay Reduction} \approx 1.0\text{ to } 1.5\text{ Days}$$

1. Attenuates Insulin Resistance: Ingestion of carbohydrate stimulates endogenous insulin secretion prior to surgical trauma. This primes insulin receptor signaling and maintains peripheral glucose uptake, cutting postoperative insulin resistance by up to $50\%$.
2. Preserves Glycogen Stores: Maximizes hepatic and skeletal muscle glycogen reserves, preventing intraoperative glycogen depletion and blunting post-surgical hepatic gluconeogenesis.
3. Reduces Muscle Proteolysis: Suppresses ubiquitin-proteasome activation, decreasing post-surgical nitrogen excretion and sparing skeletal muscle mass.
4. Symptom Relief: Significantly reduces preoperative thirst, hunger, anxiety, and postoperative nausea, vomiting, and fatigue.
5. Contraindications & Diabetes Management: Preoperative carbohydrate loading is safe and feasible in well-controlled type 2 diabetes mellitus when combined with tailored glycemic protocols; however, it is contraindicated in patients with severe gastroparesis, gastric outlet obstruction, emergency procedures, or uncontrolled, brittle diabetes.

---

Preoperative Nutritional Optimization in Severe Malnutrition

Severe baseline malnutrition is one of the most powerful independent predictors of postoperative complications, including anastomotic disruption, surgical site infections, pulmonary failure, prolonged mechanical ventilation, and mortality.

1. Diagnostic Criteria for Severe Surgical Malnutrition

Under consensus criteria from the American Society for Parenteral and Enteral Nutrition (ASPEN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), surgical candidates are classified as having severe nutritional risk when exhibiting any of the following:

• Unintentional weight loss $> 10\%\text{ to } 15\%$ over the preceding 6 months;
• Body Mass Index (BMI) $< 18.5\text{ kg/m}^2$;
• Serum albumin $< 3.0\text{ g/dL}$ (in the absence of acute severe hepatic or renal dysfunction);
• Subjective Global Assessment (SGA) Grade C (severely malnourished) or Nutritional Risk Screening 2002 (NRS-2002) score $\ge 5$.

2. The 7-to-14 Day Optimization Window

+-----------------------------------------------------------------------------------------+
|                 THE PREOPERATIVE NUTRITIONAL OPTIMIZATION TIMELINE                      |
+-----------------------------------------------------------------------------------------+
| Duration              | Cellular & Clinical Impact      | Recommendation                |
| --------------------- | ------------------------------- | ----------------------------- |
| < 7 Days              | Inadequate to restore cellular  | INEFFECTIVE: Delays surgery   |
|                       | immunity or protein synthesis   | without reducing complications|
| --------------------- | ------------------------------- | ----------------------------- |
| 7 to 14 Days          | Restores hepatic protein synth, | OPTIMAL WINDOW: Reduces       |
|                       | mitochondrial function, and     | postoperative infections and  |
|                       | blunts wound failure by ~50%    | mortality significantly       |
| --------------------- | ------------------------------- | ----------------------------- |
| > 14 Days             | Diminishing clinical returns;   | NOT RECOMMENDED: Undue delay  |
|                       | risks oncologic disease spread  | for cancer resections         |
+-----------------------------------------------------------------------------------------+

• The Evidence-Based Rule: In severely malnourished patients undergoing major elective gastrointestinal, thoracic, or oncologic surgery, delaying elective surgery for 7 to 14 days of specialized nutritional support (high-protein oral nutritional supplements, enteral nutrition, or parenteral nutrition if the gut is non-functional) reduces postoperative morbidity by up to $50\%$ and significantly decreases mortality.
• The Inefficacy of Short-Term Nutrition ($< 7\text{ Days}$): Initiating specialized nutrition support for fewer than 7 days provides no measurable clinical benefit. It is biologically insufficient to replenish cellular glycogen, restore mitochondrial enzyme function, or stimulate collagen synthesis, while unnecessarily postponing surgery.
• Route Selection: Enteral nutrition (via oral nutritional supplements or tube feeding) is preferred. Total parenteral nutrition (TPN) is indicated only when severe gastrointestinal obstruction, high-output fistulas, or intractable malabsorption precludes enteral intake.

---

Postoperative Feeding & Care: Decompression & Motility

1. Early Postoperative Enteral Feeding

Historically, surgical patients were kept strictly NPO for days postoperatively until the return of flatus or bowel sounds, driven by the erroneous belief that early intraluminal contents would disrupt fresh surgical anastomoses. Extensive physiological evidence demonstrates:

• While colonic motility is stunned for $48\text{ to } 72\text{ hours}$ post-laparotomy, small bowel motility and absorptive capacity return within 4 to 8 hours after surgery.
• Clinical Guidelines: Oral fluids, oral nutritional supplements, or enteral tube feeding should be initiated within 24 hours of surgery.
• Safety at Anastomoses: Multiple randomized trials and meta-analyses prove that early feeding does not increase the risk of anastomotic leakage or wound dehiscence. Instead, early luminal nutrients stimulate splanchnic blood flow, maintain mucosal tight junctions, stimulate secretory IgA, and reduce postoperative infectious complications.

2. Sham Feeding (Chewing Gum)

Chewing sugar-free gum for $15\text{ to } 30\text{ minutes}$ three to four times daily starting on postoperative day 1 is an established ERAS intervention:

• Mechanism: Activates cephalic-vagal neural pathways, stimulating salivary, gastric, and pancreaticobiliary secretions and triggering the release of gastrointestinal hormones (gastrin, neurotensin, motilin).
• Clinical Outcomes: Significantly accelerates the return of gastrointestinal motility, shortens the time to first flatus by 12 to 24 hours, shortens time to first bowel movement, and reduces the incidence of postoperative paralytic ileus.

3. Obsolescence of Routine Nasogastric Decompression

The routine use of prophylactic nasogastric (NG) tubes until the return of bowel function is obsolete, ineffective, and harmful:

• Lack of Benefit: Routine NG decompression does not hasten the return of bowel motility, does not protect gastrointestinal anastomoses, and does not reduce the incidence of abdominal distention or vomiting.
• Documented Harm: Routine NG tubes cause painful pharyngeal irritation, interfere with normal glottic closure, impair deep breathing and coughing, and lead directly to a significant increase in atelectasis, aspiration pneumonia, and postoperative fever.
• Current Practice: NG tubes should be removed immediately following extubation in the operating theater. Nasogastric decompression is reserved strictly for therapeutic management in patients who develop persistent abdominal distention, nausea, or active vomiting secondary to mechanical obstruction or severe ileus.

---

Immune-Modulating Nutrition (Immunonutrition)

Immune-modulating nutrition formulas are specialized enteral diets enriched with pharmaconutrients designed to modulate inflammatory cascades and enhance host immunocompetence.

+-----------------------------------------------------------------------------------------+
|                    CORE COMPONENTS OF SURGICAL IMMUNONUTRITION                          |
+-----------------------------------------------------------------------------------------+
| Substrate             | Biological Mechanism            | Clinical Target               |
| --------------------- | ------------------------------- | ----------------------------- |
| L-Arginine            | Substrate for Nitric Oxide (NO) | Restores T-lymphocyte function|
|                       | and Ornithine / Polyamines      | Promotes collagen deposition  |
| --------------------- | ------------------------------- | ----------------------------- |
| Omega-3 Fatty Acids   | Displaces Arachidonic Acid from | Shifts eicosanoids to less    |
| (EPA and DHA)         | cell membrane phospholipids     | inflammatory 3- & 5-series    |
| --------------------- | ------------------------------- | ----------------------------- |
| Dietary Nucleotides   | Essential building blocks for   | Supports rapid turnover of    |
| (RNA / DNA bases)     | purine/pyrimidine synthesis     | enterocytes and immune cells  |
+-----------------------------------------------------------------------------------------+

1. Mechanisms of Key Pharmaconutrients

• L-Arginine: Becomes a conditionally essential amino acid following surgical trauma. Arginine is the obligate substrate for inducible nitric oxide synthase (iNOS), generating nitric oxide (NO) which improves microvascular tissue perfusion and antimicrobial activity. Concurrently, arginase metabolizes arginine into ornithine and putrescine, the precursors for polyamines and proline, which are essential for fibroblast proliferation, collagen synthesis, and wound tensile strength. Furthermore, arginine restores expression of the $CD3\zeta$ subunit of the T-cell receptor, reversing post-surgical T-cell dysfunction.
• Omega-3 Fatty Acids (Eicosapentaenoic Acid [EPA] & Docosahexaenoic Acid [DHA]): Incorporate into cell membranes, competitively inhibiting arachidonic acid (omega-6) metabolism. This downregulates the synthesis of pro-inflammatory 2-series prostaglandins ($PGE_2$) and 4-series leukotrienes ($LTB_4$), shifting production toward the less inflammatory 3-series prostaglandins ($PGE_3$), 5-series leukotrienes ($LTB_5$), and specialized pro-resolving mediators (resolvins, protectins).
• Nucleotides: Provide ready purine and pyrimidine bases required for rapid cellular turnover of mucosal enterocytes and clonal proliferation of lymphocytes.

2. Dosing Protocol & Clinical Outcomes

• Administration: Administered for $5\text{ to } 7\text{ days}$ preoperatively ($500\text{ to } 1000\text{ mL/day}$, providing at least $12\text{ to } 15\text{ g/day}$ of supplemental arginine) in patients undergoing major elective upper gastrointestinal, colorectal, or head and neck cancer surgery, regardless of baseline nutritional status.
• Evidence-Based Outcomes: Meta-analyses of dozens of randomized controlled trials demonstrate that perioperative immunonutrition reduces postoperative infectious complications by $40\%\text{ to } 50\%$ (primarily reducing surgical site infections and intra-abdominal abscesses) and shortens hospital length of stay by $2\text{ to } 3\text{ days}$.

3. Critical Sepsis Contraindication

Population Boundary: Evidence for perioperative immunonutrition applies to selected elective surgical populations. It should not be extrapolated to routine treatment of severe sepsis, and no enteral formula should be started during uncontrolled shock or escalating vasopressor support. The proposed arginine–nitric-oxide harm mechanism remains a theoretical concern rather than a universal proven effect.